Relapsed or Refractory Hodgkin Lymphoma
8 clinical trials · Condition
◉ Watch Relapsed or Refractory Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment (NCT06931613) | St. Petersburg State Pavlov Medical University | 2022-06-01 |
| Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma (NCT03618550) | Memorial Sloan Kettering Cancer Center | 2018-08-01 |
| Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma (NCT01965119) | Samsung Medical Center | 2013-11-15 |
| A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01572519) | Janssen Research & Development, LLC | 2012-07-17 |
| Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma (NCT01492088) | Millennium Pharmaceuticals, Inc. | 2012-04-16 |
Track Relapsed or Refractory Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.